CME Group Inc (CME) Shares Sold by Bamco Inc. NY
Bamco Inc. NY lowered its position in shares of CME Group Inc (NASDAQ:CME) by 3.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,679 shares of the financial services provider’s stock after selling 1,317 shares during the quarter. Bamco Inc. NY’s holdings in CME Group were worth $5,791,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of CME. IFP Advisors Inc boosted its position in shares of CME Group by 2.4% during the 2nd quarter. IFP Advisors Inc now owns 2,998 shares of the financial services provider’s stock worth $375,000 after purchasing an additional 71 shares in the last quarter. Sigma Planning Corp boosted its position in shares of CME Group by 7.6% during the 2nd quarter. Sigma Planning Corp now owns 3,642 shares of the financial services provider’s stock worth $456,000 after purchasing an additional 256 shares in the last quarter. Wedbush Securities Inc. boosted its position in shares of CME Group by 22.6% during the 2nd quarter. Wedbush Securities Inc. now owns 4,330 shares of the financial services provider’s stock worth $542,000 after purchasing an additional 798 shares in the last quarter. Advisors Asset Management Inc. boosted its position in shares of CME Group by 32.5% during the 2nd quarter. Advisors Asset Management Inc. now owns 27,964 shares of the financial services provider’s stock worth $3,502,000 after purchasing an additional 6,866 shares in the last quarter. Finally, Dupont Capital Management Corp bought a new position in shares of CME Group during the 2nd quarter worth about $248,000. 83.17% of the stock is currently owned by institutional investors and hedge funds.
CME Group Inc (NASDAQ:CME) opened at $151.61 on Thursday. CME Group Inc has a 1 year low of $113.27 and a 1 year high of $155.29. The firm has a market cap of $51,590.00, a PE ratio of 31.95, a P/E/G ratio of 3.14 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter last year, the firm earned $1.05 EPS. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. equities analysts expect that CME Group Inc will post 4.78 earnings per share for the current year.
The firm also recently declared a None dividend, which will be paid on Monday, January 15th. Investors of record on Thursday, December 28th will be given a $3.50 dividend. The ex-dividend date of this dividend is Wednesday, December 27th. CME Group’s payout ratio is 59.86%.
A number of research firms have recently issued reports on CME. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Citigroup increased their price objective on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Barclays began coverage on shares of CME Group in a research report on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective on the stock. Wells Fargo & Company increased their price objective on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. Finally, Keefe, Bruyette & Woods reissued a “hold” rating and set a $133.00 price objective on shares of CME Group in a research report on Thursday, September 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $141.75.
In related news, insider Hilda Harris Piell sold 1,350 shares of the firm’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $138.00, for a total value of $186,300.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 5,175 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,628 shares of company stock worth $5,288,800. 0.57% of the stock is owned by insiders.
WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/cme-group-inc-cme-shares-sold-by-bamco-inc-ny/1762750.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with Analyst Ratings Network's FREE daily email newsletter.